Results 251 to 260 of about 531,523 (312)

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Concurrent jamming and mesenchymal-to-epithelial transitions during airway basal stem cell differentiation. [PDF]

open access: yesiScience
Mitchel JA   +8 more
europepmc   +1 more source

Restructuring breeding programs 1: Integration of diversity. [PDF]

open access: yesGenet Sel Evol
Niehoff TAM, Ten Napel J, Calus MPL.
europepmc   +1 more source

Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases. [PDF]

open access: yesEur J Hum Genet
Clancy J   +7 more
europepmc   +1 more source

Activation of Thioglycosides with Ferric Chloride: Scope and Mechanism. [PDF]

open access: yesACS Omega
Ridgway LM   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Recent progress on donor and donor–donor carbenes

Chemical Society Reviews, 2020
This review highlights the recent advances in donor and donor–donor carbenes.
Dong Zhu   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy